🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

313,52 USD

Máx. histórico

322,75

4 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-2,86%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,12%

Cierre anterior

307,02

Rango de hoy

309,46 – 317,76

Volumen hoy

195.564

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
33,04 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 20 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/08/2021 70,98 70,98 68,96 69,21 -2,26% 2,85% 218.168
30/07/2021 74,17 74,82 70,37 70,81 -4,58% 6,00% 235.160
29/07/2021 76,94 78,32 73,77 74,21 -3,64% 5,90% 326.050
28/07/2021 75,11 77,64 74,31 77,01 +2,52% 4,43% 282.769
27/07/2021 75,58 75,58 73,74 75,12 -0,99% 2,44% 215.443
26/07/2021 75,92 76,99 75,64 75,88 -0,30% 1,77% 133.370
23/07/2021 76,96 77,04 75,30 76,11 -0,22% 2,26% 134.652
22/07/2021 76,98 78,74 76,15 76,28 -1,51% 3,36% 98.264
21/07/2021 76,42 78,03 75,33 77,45 +1,40% 3,53% 116.698
20/07/2021 75,93 78,13 75,60 76,38 +0,88% 3,34% 213.520
19/07/2021 69,91 76,12 69,32 75,71 +7,23% 9,73% 268.823
16/07/2021 73,03 74,01 70,56 70,61 -2,28% 4,72% 264.655
15/07/2021 73,43 73,43 71,53 72,25 -1,98% 2,58% 240.610
14/07/2021 76,23 76,23 73,56 73,71 -3,13% 3,49% 237.725
13/07/2021 77,98 78,48 76,01 76,09 -3,47% 3,17% 203.741
12/07/2021 80,88 80,88 78,69 78,83 -2,35% 2,71% 114.775
09/07/2021 80,33 80,84 79,13 80,72 +1,16% 2,12% 109.004
08/07/2021 78,75 80,82 78,37 79,80 -0,80% 3,12% 173.284
07/07/2021 80,61 81,34 78,63 80,44 +0,08% 3,37% 158.376
06/07/2021 83,47 83,47 79,97 80,38 -3,30% 4,20% 204.062
02/07/2021 84,75 84,75 83,05 83,13 -1,97% 2,00% 169.117
01/07/2021 82,40 84,95 82,40 84,80 +3,61% 3,09% 154.209
30/06/2021 83,92 83,92 81,14 81,84 -2,86% 3,32% 162.063
29/06/2021 85,93 86,23 83,71 84,25 -1,80% 2,94% 226.344
28/06/2021 87,77 88,29 84,71 85,79 -1,33% 4,08% 299.921
25/06/2021 84,92 87,03 84,20 86,94 +3,12% 3,34% 1.271.339
24/06/2021 80,62 84,43 80,62 84,31 +5,43% 4,73% 266.739
23/06/2021 80,96 81,97 79,69 79,97 -1,10% 2,81% 201.177
22/06/2021 79,92 81,09 79,13 80,85 +0,49% 2,45% 197.329
21/06/2021 79,36 81,58 78,92 80,46 +1,87% 3,35% 298.318